$JAZZ 8-K SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Results of Operations and Financial Condition Estimated Q3 Financial Impacts Related to the Actio Biosciences, Inc. Acquisition
09 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company”), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier ...
23 Sep 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant This AMENDMENT No. 4, dated as of September 23, 2026 (this “Amendment”), to the Credit Agreement, dated as of May 5, 2021 (as amended by that certain LIBOR Successor Rate Conforming Changes Amendment, dated as of June 7, 2023, that certa...
15 Sep 2026	8-K: Regulation FD Disclosure Acquisition adds ABS-1230, a clinical-stage, potential first-in-class precision therapy for KCNT1-related epilepsy
31 Aug 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
25 Aug 2026	8-K: Other Events
10 Aug 2026	8-K: Entry into a Material Definitive Agreement
10 Aug 2026	8-K: Regulation FD Disclosure
03 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders
29 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
05 May 2026	8-K: Results of Operations and Financial Condition
24 Feb 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Results of Operations and Financial Condition
17 Nov 2025	8-K: Other Events
05 Nov 2025	8-K: Results of Operations and Financial Condition
28 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation
22 Oct 2025	8-K: Other Events
05 Aug 2025	8-K: Results of Operations and Financial Condition
25 Jul 2025	8-K: Submission of Matters to a Vote of Security Holders

Comments